BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 28498498)

  • 1. Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States.
    Moyo P; Simoni-Wastila L; Griffin BA; Onukwugha E; Harrington D; Alexander GC; Palumbo F
    Addiction; 2017 Oct; 112(10):1784-1796. PubMed ID: 28498498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription drug monitoring programs: Assessing the association between "best practices" and opioid use in Medicare.
    Moyo P; Simoni-Wastila L; Griffin BA; Harrington D; Alexander GC; Palumbo F; Onukwugha E
    Health Serv Res; 2019 Oct; 54(5):1045-1054. PubMed ID: 31372990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP).
    Lin DH; Lucas E; Murimi IB; Jackson K; Baier M; Frattaroli S; Gielen AC; Moyo P; Simoni-Wastila L; Alexander GC
    Addiction; 2017 Feb; 112(2):311-319. PubMed ID: 27658522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.
    Lin HC; Wang Z; Boyd C; Simoni-Wastila L; Buu A
    Addict Behav; 2018 Jan; 76():348-354. PubMed ID: 28898808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mandatory Review of Prescription Drug Monitoring Program Before Issuance of a Controlled Substance Results in Overall Reduction of Prescriptions Including Opioids and Benzodiazepines.
    Manders L; Abd-Elsayed A
    Pain Physician; 2020 Jun; 23(3):299-304. PubMed ID: 32517396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription Drug Monitoring Programs Produce a Limited Impact on Painkiller Prescribing in Medicare Part D.
    Yarbrough CR
    Health Serv Res; 2018 Apr; 53(2):671-689. PubMed ID: 28101955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prescription drug monitoring program in a multifactorial approach to the opioid crisis: PDMP data, Pennsylvania, 2016-2020.
    Adalbert JR; Syal A; Varshney K; George B; Hom J; Ilyas AM
    BMC Health Serv Res; 2023 Apr; 23(1):364. PubMed ID: 37046254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.
    Rutkow L; Chang HY; Daubresse M; Webster DW; Stuart EA; Alexander GC
    JAMA Intern Med; 2015 Oct; 175(10):1642-9. PubMed ID: 26280092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of trends in opioid dispensing patterns between Medicaid pharmacy claims and prescription drug monitoring program data.
    El Ibrahimi S; Hallvik S; Johnston K; Leichtling G; Choo E; Hartung DM
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1168-1174. PubMed ID: 32939909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Postoperative Opioid Prescriptions Before and After Implementation of a Mandatory Prescription Drug Monitoring Program.
    Shenoy R; Wagner Z; Kirkegaard A; Romanelli RJ; Mudiganti S; Mariano L; Martinez M; Zanocco K; Watkins KE
    JAMA Health Forum; 2021 Oct; 2(10):e212924. PubMed ID: 35977161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
    Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
    JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Past-year Prescription Drug Monitoring Program Opioid Prescriptions and Self-reported Opioid Use in an Emergency Department Population With Opioid Use Disorder.
    Hawk K; D'Onofrio G; Fiellin DA; Chawarski MC; O'Connor PG; Owens PH; Pantalon MV; Bernstein SL
    Acad Emerg Med; 2018 May; 25(5):508-516. PubMed ID: 29165853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the Direct Costs of Outpatient Opioid Prescriptions: A Retrospective Analysis of Data from the Rhode Island Prescription Drug Monitoring Program.
    Aroke H; Buchanan A; Wen X; Ragosta P; Koziol J; Kogut S
    J Manag Care Spec Pharm; 2018 Mar; 24(3):214-224. PubMed ID: 29485950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in opioid and other analgesic prescribing following voluntary and mandatory prescription drug monitoring program implementation: A time series analysis of early outcomes.
    Nielsen S; Picco L; Russell G; Pearce C; Andrew NE; Lubman DI; Bell JS; Buchbinder R; Xia T
    Int J Drug Policy; 2023 Jul; 117():104053. PubMed ID: 37209441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstate data sharing of prescription drug monitoring programs and associated opioid prescriptions among patients with non-cancer chronic pain.
    Lin HC; Wang Z; Simoni-Wastila L; Boyd C; Buu A
    Prev Med; 2019 Jan; 118():59-65. PubMed ID: 30316875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in prescription drug monitoring program use by prescriber specialty.
    Sun BC; Lupulescu-Mann N; Charlesworth CJ; Kim H; Hartung DM; Deyo RA; John McConnell K
    J Subst Abuse Treat; 2018 Nov; 94():35-40. PubMed ID: 30243415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription drug monitoring programs operational characteristics and fatal heroin poisoning.
    Martins SS; Ponicki W; Smith N; Rivera-Aguirre A; Davis CS; Fink DS; Castillo-Carniglia A; Henry SG; Marshall BDL; Gruenewald P; Cerdá M
    Int J Drug Policy; 2019 Dec; 74():174-180. PubMed ID: 31627159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating short- and long-term impacts of a Medicaid "lock-in" program on opioid and benzodiazepine prescriptions dispensed to beneficiaries.
    Naumann RB; Marshall SW; Lund JL; Gottfredson NC; Ringwalt CL; Skinner AC
    Drug Alcohol Depend; 2018 Jan; 182():112-119. PubMed ID: 29150151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review.
    Rhodes E; Wilson M; Robinson A; Hayden JA; Asbridge M
    BMC Health Serv Res; 2019 Nov; 19(1):784. PubMed ID: 31675963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicians' Perspectives Regarding Prescription Drug Monitoring Program Use Within the Department of Veterans Affairs: a Multi-State Qualitative Study.
    Radomski TR; Bixler FR; Zickmund SL; Roman KM; Thorpe CT; Hale JA; Sileanu FE; Hausmann LRM; Thorpe JM; Suda KJ; Stroupe KT; Gordon AJ; Good CB; Fine MJ; Gellad WF
    J Gen Intern Med; 2018 Aug; 33(8):1253-1259. PubMed ID: 29520747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.